Diagnoptics News

What's new?

Read all news items about the AGE Reader and Diagnoptics.

AGE Reader presented at German national diabetes conference in Berlin.

Groningen, the Netherlands – November 23, 2012.

At the recent so-called DDG Herbstagung dr. Kaltheuner gave a very interesting presentation about the daily clinical use of the AGE Reader.

Dr. Kaltheuner presented about his experiences with the AGE Reader in estimating cardiovascular risk in his diabetes patients. In his presentation dr. Kaltheuner stated that the current risk scores to estimate the cardiovascular risk of diabetics are far from perfect. An alternative measurement of cardiovascular risk would be very helpful, to decide whether or not to intensify treatment.

His conclusion was that the AGE Reader is a very easy method to use in daily practice that can be of added value in determining the cardiovascular risk of diabetes patients.

Link: http://www.herbsttagung-ddg.de/programm/freitag.html?getsinglehtml=21&druck=show

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The 'AGE Reader mu' is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.